Beyond inducing weight loss, these treatments have demonstrated benefits on obesity-related complications, including neuropsychiatric and substance use disorders, peripheral vascular disease, arthritis, MASLD, hypertension and renal disorders, positioning them as a central focus in current obesity research [3]
You may also qualify if you have a BMI of 27 or higher accompanied by at least one weight-related medical condition, such as hypertension (high blood pressure), type 2 diabetes, high cholesterol, or obstructive sleep apnea
The risk is lower when samples are tested before large orders are placed
Research has suggested that berberine can induce GLP-1 secretion in a laboratory setting but the benefits to human health are less certain